| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
171,232
|
151,730
|
131,554
|
157,418
| | Cost of Revenue | 148,451 | 134,119 | 111,790 | 140,549 | | |
Gross Profit
|
22,781
|
17,611
|
19,764
|
16,869
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 8,979 | 9,409 | 9,779 | 8,267 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 3,507 | 3,099 | 3,066 | 2,999 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
13,748
|
5,103
|
6,919
|
5,603
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
| 3 |
-
|
-
|
|
Earnings Before Interest And Taxes | 13,748 | 5,106 | 6,919 | 5,603 |
|
Interest Expense | 1,754 | 505 | 450 | 477 |
|
Income Before Tax | 11,994 | 4,601 | 6,469 | 5,126 |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 15,447 | 4,601 | 6,469 | 5,126 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
11,994
|
4,601
|
6,469
|
5,126
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
11,994
|
4,601
|
6,469
|
5,126
|
|
0.97(2.62%) 10:39AM EDT - Nasdaq Real Time Price